𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting the hemangioblast with a novel cell type-specific enhancer

✍ Scribed by Vera Teixeira; Natacha Arede; Rui Gardner; Joaquín Rodríguez-León; Ana T Tavares


Publisher
BioMed Central
Year
2011
Tongue
English
Weight
509 KB
Volume
11
Category
Article
ISSN
1471-213X

No coin nor oath required. For personal study only.

✦ Synopsis


Background

Hemangioblasts are known as the common precursors for primitive hematopoietic and endothelial lineages. Their existence has been supported mainly by the observation that both cell types develop in close proximity and by in vitro differentiation and genetic studies. However, more compelling evidence will arise from tracking their cell fates using a lineage-specific marker.

Results

We report the identification of a hemangioblast-specific enhancer (Hb) located in the cis-regulatory region of chick Cerberus gene (cCer) that is able to direct the expression of enhanced green fluorescent protein (eGFP) to the precursors of yolk sac blood and endothelial cells in electroporated chick embryos. Moreover, we present the Hb-eGFP reporter as a powerful live imaging tool for visualizing hemangioblast cell fate and blood island morphogenesis.

Conclusions

We hereby introduce the Hb enhancer as a valuable resource for genetically targeting the hemangioblast population as well as for studying the dynamics of vascular and blood cell development.


📜 SIMILAR VOLUMES


Target cell-restricted and -enhanced apo
✍ Edwin Bremer; Jos Kuijlen; Douwe Samplonius; Henning Walczak; Lou de Leij; Wijna 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 240 KB

## Abstract The apparent tumor selective apoptosis‐inducing activity of recombinant soluble TNF‐related apoptosis‐inducing ligand (TRAIL) has aroused much interest for use in clinical application. However, to exploit fully its therapeutic potential, the characteristics of both the TRAIL receptor sy